UPDATE 1-Pfizer, Lilly to resume study testing pain drug
March 23, 2015 at 09:53 AM EDT
March 23 (Reuters) - Pfizer Inc and Eli Lilly and Co will resume a late-stage study testing their pain drug tanezumab after the U.S. Food and Drug Administration lifted a partial hold on it.
